Meanwhile, a number of studies have confirmed a highly significant downregulation not only in colorectal cancer but also in renal cancer, strongly supporting a tumor-suppressive function of TMIGD1 and suggesting that TMIGD1 expression may be used as a prognostic marker [19, 63, 69]. Here, TMIGD1 is linked to renal carcinoma.